BioPharm Communications

New Hope, United States Founded: 2005 • Age: 21 yrs Acquired By Indegene
Marketing services are provided to pharmaceutical and biopharma companies.

About BioPharm Communications

BioPharm Communications is a Healthcare company based in New Hope (United States) founded in 2005, and was acquired by Indegene in October 2025. Marketing services are provided to pharmaceutical and biopharma companies. The company has 37 employees. BioPharm Communications offers products and services including Always ON Network, Moments Solution, and Peer-Based Deep Education. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its legal entity is BIOPHARM COMMUNICATIONS, LLC. Its competitors include Target RWE, Secura Bio and Hylant; 1 of its 3 listed competitors has raised funding.

Company details

BioPharm Communications was established in 2005 and is headquartered in New Hope, United States. Marketing services are delivered to firms in the pharmaceutical and biopharmaceutical sectors. Operations center on communication strategies, including content development and promotional support tailored to healthcare regulations. The focus remains on assisting clients with industry-specific outreach, drawing from over 15 years of sector experience. Geographic operations are primarily U.S.-based, supporting biopharma entities nationwide.

Key Metrics
  • Latest Funding Round
    $18.5M (USD), Debt – Conventional

    Mar 2012

  • Investors
    Indegene

    & 5 more

  • Employee Count
    37
  • Acquired by
    Indegene

    & 2 more

    (Oct 2025)

Products & Services of BioPharm Communications

BioPharm Communications offers a comprehensive portfolio of products and services, including Always ON Network, Moments Solution, and Peer-Based Deep Education.

Always ON Network
Marketing Platform

Drives reach and engagement for healthcare decision makers through digital channels.

Moments Solution
Targeted Activation

Provides trigger-based opportunities to impact HCP decisions and behavior effectively.

Peer-Based Deep Education
Education Tools

Offers KOL-led programs for deep clinical education and brand message endorsement.

Funding Insights of BioPharm Communications

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $18.5M
  • First Round $18.5M

    (Mar 2012)

  • Investors Count 3

All 1 funding rounds of BioPharm Communications with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2012$18.5MDebt – Conventional––
Valuation history

6 investors in total: 6 institutional.

Investors in BioPharm Communications

BioPharm Communications has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Indegene, Southfield Capital and Abacus Finance.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Abacus Finance is engaged in providing tailored credit solutions to lower-middle market companies.
abacusfinance.comNew York, United States
Private equity and debt investments are focused on multiple sectors.
boathousecapital.comWayne, United States
cmsmezz.com
Private equity investment firm
2002southfieldcapital.comGreenwich, United States
Suite solutions are provided for payers and healthcare providers.
1998indegene.comPrinceton, United States
Global healthcare communications network uniting agencies for consulting and media services.
2016omnicomhealthgroup.comNew York, United States
Premium access

Investor details for BioPharm Communications

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of BioPharm Communications

5 dated milestones of BioPharm Communications across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioPharm Communications is founded.
  2. Funding First funding round of $18.5M.
  3. Exit Acquired by Southfield Capital.
  4. Exit Acquired by Omnicom Health Group.
  5. Exit Acquired by Indegene.

Competitors of BioPharm Communications

BioPharm Communications has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and Hylant.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
targetrwe.com2017Durham, United States116
Marketing services to the pharmaceutical industry are provided.
securabio.com2018Henderson, United States$55M
Consulting services for market access and health outcomes are provided.
hylant.com1935Toledo, United States849
Offers business insurance, employee benefits, and risk consulting services worldwide.
Premium access

Detailed competitors of BioPharm Communications

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioPharm Communications

The website of BioPharm Communications (biopharmcommunications.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 57.8% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as BioPharm Communications (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BioPharm Communications

BioPharm Communications was founded in 2005 and raised its 1st funding round 7 years after it was founded.

BioPharm Communications is headquartered in New Hope, United States.

BioPharm Communications has 37 employees.

BioPharm Communications was established in 2005 and is headquartered in New Hope, United States. Marketing services are delivered to firms in the pharmaceutical and biopharmaceutical sectors. Operations center on communication strategies, including content development and promotional support tailored to healthcare regulations. The focus remains on assisting clients with industry-specific outreach, drawing from over 15 years of sector experience. Geographic operations are primarily U.S.-based, supporting biopharma entities nationwide.

BioPharm Communications's top competitors include Target RWE, Secura Bio and Hylant.

BioPharm Communications offers Always ON Network, Moments Solution, and Peer-Based Deep Education.

BioPharm Communications has 6 investors. Key investors include Indegene, Southfield Capital, Abacus Finance, Boathouse Capital, and CMS Mezzanine Fund.

BioPharm Communications operates through Biopharm Communications, Llc.

Yes. BioPharm Communications was acquired by Omnicom Health Group in May 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available